CBLL
Ceribell Inc.

134
Mkt Cap
$771.22M
Volume
146,137.00
52W High
$26.04
52W Low
$10.01
PE Ratio
-14.35
CBLL Fundamentals
Price
$20.79
Prev Close
$20.90
Open
$20.98
50D MA
$21.03
Beta
1.74
Avg. Volume
375,778.70
EPS (Annual)
-$1.13
P/B
4.69
Rev/Employee
$232,896.80
$755.40
Loading...
Loading...
News
all
press releases
Insider Selling: CeriBell (NASDAQ:CBLL) VP Sells 5,556 Shares of Stock
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) VP David Foehr sold 5,556 shares of the firm's stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $20.00, for a...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
CeriBell (NASDAQ:CBLL) VP David Foehr Sells 5,556 Shares
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) VP David Foehr sold 5,556 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $20.00...
MarketBeat·6d ago
News Placeholder
CeriBell, Inc. (NASDAQ:CBLL) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) have been given an average rating of "Moderate Buy" by the seven brokerages that are covering the firm, MarketBeat reports. One analyst has...
MarketBeat·6d ago
News Placeholder
CeriBell (NASDAQ:CBLL) Director Sells $573,500.00 in Stock
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) Director Josef Parvizi sold 25,000 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $22.94, for...
MarketBeat·21d ago
News Placeholder
Josef Parvizi Sells 25,000 Shares of CeriBell (NASDAQ:CBLL) Stock
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) Director Josef Parvizi sold 25,000 shares of the firm's stock in a transaction dated Thursday, January 15th. The stock was sold at an average price of...
MarketBeat·22d ago
News Placeholder
CeriBell Maps 2026 Growth at JPMorgan MedTech, Eyes Delirium and Stroke EEG Expansion
CeriBell (NASDAQ:CBLL) outlined its recent progress and 2026 priorities at a JPMorgan MedTech event, emphasizing continued growth in acute-care seizure detection and an expanding roadmap for...
MarketBeat·28d ago
News Placeholder
CeriBell (NASDAQ:CBLL) CTO Sells $235,352.16 in Stock
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) CTO Raymond Woo sold 11,112 shares of CeriBell stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of...
MarketBeat·1mo ago
News Placeholder
Rebecca Robertson Sells 2,500 Shares of CeriBell (NASDAQ:CBLL) Stock
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) Director Rebecca Robertson sold 2,500 shares of CeriBell stock in a transaction on Friday, January 2nd. The stock was sold at an average price of...
MarketBeat·1mo ago
News Placeholder
Raymond Woo Sells 11,112 Shares of CeriBell (NASDAQ:CBLL) Stock
CeriBell, Inc. (NASDAQ:CBLL - Get Free Report) CTO Raymond Woo sold 11,112 shares of the firm's stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $21.18...
MarketBeat·1mo ago
News Placeholder
CBLL Wins FDA Breakthrough Status for AI-Based LVO Stroke Detection
Ceribell wins FDA Breakthrough status for its AI-driven EEG solution to detect and monitor LVO strokes in hospitals, boosting credibility and growth outlook.
Zacks·1mo ago
<
1
2
...
>

Latest CBLL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.